Evidence map›Paper›PMID 33718262›Full record

Trial reportFrontiers in cellular and infection microbiology2021

A Novel Molecular Method for Simultaneous Identification of

Linying Lu, Minxu Li, Yinghui Li, Min Jiang, Yixiang Jiang, Xiaolu Shi, Le Zuo, Lei Wang, Shengzhe Bian, Yaqun Qiu and 5 more

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Linying LuSchool of Public Health, University of South China, Hengyang, China.
Minxu LiShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Yinghui LiShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Min JiangShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Yixiang JiangShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Xiaolu ShiShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Le ZuoShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Lei WangShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Shengzhe BianSchool of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, China.
Yaqun QiuShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Rui CaiShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Yiqun LiaoSchool of Life Sciences, Xiamen University, Xiamen, China.
Qingge LiSchool of Life Sciences, Xiamen University, Xiamen, China.
Liqiang LiShenzhen Key Laboratory of Unknown Pathogen Identification, BGI-Shenzhen, Shenzhen, China.
Qinghua HuSchool of Public Health, University of South China, Hengyang, China.
Shenzhen Center for Disease Control and Prevention · CNBGI Group (China) · CNUniversity of South China · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The serotyping of

Indexed as

Vibrio InfectionsVibrio parahaemolyticusHumansReproducibility of ResultsSerogroupSerotypingK-serogroupsmolecular identificationmultiplex ligation reaction based on probe melting curve analysisVibrio parahaemolyticusvibriosis surveillance

Identifiers

PMID33718262
PMCPMC7953158
OpenAlexW3135797254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.